发明名称 THERAPEUTIC ANTI-HCV (AL9) COMPOUNDS
摘要 The present invention provides synthetic HCV epitopes, antibodies that recognize and bind to the synthetic HCV epitopes, polynucleotides that encode the synthetic HCV epitopes, and immune effector cells raised in response to the presentation of the synthetic HCV epitopes. The invention further provides methods for inducing an immune response and for administering immunotherapy to a subject by delivering the compositions of the invention.
申请公布号 WO2004071414(A3) 申请公布日期 2005.06.02
申请号 WO2004US03044 申请日期 2004.02.03
申请人 GENZYME CORPORATION;THE GENERAL HOSPITAL CORPORATION;NICOLETTE, CHARLES, A.;WALKER, BRUCE, D. 发明人 NICOLETTE, CHARLES, A.;WALKER, BRUCE, D.
分类号 A61K;A61K35/00;A61K38/16;A61K39/00;A61K39/395;A61K48/00;C07H21/02;C07H21/04;C07K2/00;C07K14/18;C07K16/00;C12P21/00;C12P21/06 主分类号 A61K
代理机构 代理人
主权项
地址